WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
1-Year Est. Return
17.41%
1 Year Est. Return
-17.41%
AUM
$310M
AUM Growth
-$281M
(-48%)
Holding
5
Top Buys
No buys this quarter
Top Sells
| 1 | +$118M | |
| 2 | +$92.7M | |
| 3 | +$22M | |
| 4 |
Theravance Biopharma
TBPH
|
+$15.8M |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$6.24M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Theravance Biopharma
TBPH
$743M
| $221M | 71.3% |
11,350,719
-809,261
|
|
||
|
EVFM
2
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $63M | 20.31% |
833,081
-82,508
|
|
||
|
AUTL
3
Autolus Therapeutics
AUTL
$375M
| $26M | 8.39% |
2,095,127
-9,499,107
|
|
||
|
NCNA
4
NuCana
NCNA
$6.93M
| – | – |
-424
|
|
||
5
Prothena Corp
PRTA
$552M
| – | – |
-8,773,790
|
|